Rehmann Capital Advisory Group decreased its position in shares of Aetna Inc (NYSE:AET) by 5.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,424 shares of the company’s stock after selling 263 shares during the quarter. Rehmann Capital Advisory Group’s holdings in Aetna were worth $897,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of AET. Migdal Insurance & Financial Holdings Ltd. lifted its holdings in shares of Aetna by 3,076.7% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 953 shares of the company’s stock worth $175,000 after acquiring an additional 923 shares during the last quarter. Fiera Capital Corp bought a new position in shares of Aetna in the second quarter worth about $217,000. Jennison Associates LLC lifted its holdings in shares of Aetna by 2.1% in the second quarter. Jennison Associates LLC now owns 243,407 shares of the company’s stock worth $44,665,000 after acquiring an additional 4,903 shares during the last quarter. Sei Investments Co. lifted its holdings in shares of Aetna by 2.8% in the second quarter. Sei Investments Co. now owns 224,644 shares of the company’s stock worth $41,223,000 after acquiring an additional 6,163 shares during the last quarter. Finally, FineMark National Bank & Trust bought a new position in shares of Aetna in the second quarter worth about $219,000. 82.34% of the stock is owned by institutional investors and hedge funds.
A number of research analysts have recently commented on AET shares. Zacks Investment Research reissued a “buy” rating and issued a $224.00 target price on shares of Aetna in a report on Monday, November 12th. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $204.00 price objective on shares of Aetna in a research note on Tuesday, October 30th. Citigroup upped their price objective on Aetna from $202.00 to $206.00 and gave the company a “neutral” rating in a research note on Wednesday, October 31st. Credit Suisse Group lowered their price objective on Aetna from $207.00 to $205.00 and set a “neutral” rating for the company in a research note on Wednesday, October 31st. Finally, Piper Jaffray Companies downgraded Aetna from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $212.00 to $206.00 in a research note on Tuesday, October 30th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $207.33.
Aetna (NYSE:AET) last released its earnings results on Tuesday, October 30th. The company reported $2.96 earnings per share for the quarter, beating analysts’ consensus estimates of $2.83 by $0.13. The business had revenue of $15.48 billion during the quarter, compared to the consensus estimate of $15.40 billion. Aetna had a net margin of 5.99% and a return on equity of 20.78%. The company’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.45 EPS. On average, sell-side analysts predict that Aetna Inc will post 11.38 EPS for the current fiscal year.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Recommended Story: What are trading strategies for the 52-week high/low?
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.